Hugo Lövheim

Hugo Lövheim is a Professor and Head of the Geriatric Medicine Section at Umeå University's Department of Community Medicine and Rehabilitation. He holds dual roles as a clinician and researcher specializing in geriatric medicine. His primary research focuses on the relationship between herpes simplex virus (HSV-1) infection and Alzheimer's disease, behavioral symptoms of dementia, and psychotropic drug use in elderly populations. He leads major projects including a randomized pharmacist intervention study (NCT01504672) targeting drug-related issues in dementia patients and a longitudinal cohort study on HSV-1's role in dementia onset.

Notable ongoing work includes investigating antiviral treatments' impact on Alzheimer's progression and analyzing nursing home management practices in promoting person-centered care. Lövheim is affiliated with the GERDA and U-Age research groups, and his work spans clinical practice, epidemiology, and healthcare policy. His leadership roles include directing the Geriatric Medicine Section and coordinating multicenter clinical trials.

His research outputs emphasize translational medicine, with recent focus on genetic risk factors (TREM2, APOE4), viral-biomarker interactions (amyloid-β levels), and nursing home pharmacological practices. Key collaborations involve pharmaceutical interventions, cognitive assessment tool development (Gottfries' Scale), and cross-sectional analyses of leadership impacts on healthcare outcomes.